Guillain-Barré syndrome following administration of live measles vaccine.
In a 19 month old girl and a 10 month old girl the Guillain-Barre syndrome developed within a week after they received, respectively, live measles-rubella vaccine and live measles vaccine. The older child was immune to the rubella at the time of vaccination, but both girls demonstrated a primary measles antibody response. Serum obtained during the acute and convalescent stages from the younger child was tested for antibodies against the herpes viruses (herpes simplex, Epstein-Barr virus, cytomegalovirus and varicella-zoster) and found to be negative.
D000914:Antibodies, Viral / Q000032:analysis; D005260:Female; D006564:Herpesviridae / Q000276:immunology; D006801:Humans; D007223:Infant; D008458:Measles Vaccine / Q000009:adverse effects*; D012411:Rubella Vaccine / Q000009:adverse effects; D014613:Vaccines, Attenuated / Q000009:adverse effects*
D000914:Antibodies, Viral; D008458:Measles Vaccine; D012411:Rubella Vaccine; D014613:Vaccines, Attenuated